Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Study Shows Blood-Clot Risk For Birth Control Patch Is Double That Of An Oral Contraceptive
However, According To Another Study Ortho Evra Skin Patch Use Presents No Increased Risk Of Blood Clots On February 16, 2006 Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson (J&J) unit, announced that some preliminary…
-
Adderall Safety Is Not Proven By Health Canada’s Decision To Reverse Ban On ADHD Drug
A Closer Look At How (Or Why) Adderall Got Back On The Market In Canada In the October 7, 2005 edition of Psychiatric News there was an article by Jim Rosack entitled "Canada Reverses…
-
Ortho Evra Birth Control Patch Linked To Increased Risk of Serious Blood Clots
2005 Label Change Warns About Higher Levels Of Estrogen Found In Ortho Evra In July 2005 the Associated Press (AP) published an investigative article that linked the birth control patch Ortho Evra to an…
-
FDA Wants New Safety Studies For Adderall, Other ADHD Drugs
Reports Of Serious Adverse Events Involving Sudden Death, Heart Attack, and Stroke Reports of sudden deaths, heart attacks, and strokes in both children and adults taking drugs to treat attention deficit hyperactivity disorder (ADHD)…
-
WHI Study Was Perhaps Flawed And Subsequent HRT Advice May Be Wrong
Cyclical Hormones, But Not Prempro, May Be Protective Against Heart Disease Many people will recall that in July 2002 women were told to talk to their doctor about perhaps stopping their hormone replacement therapy…
-
Bextra Will Not Return In Canada As Safety Risks Outweigh Benefits
Health Canada Safety Panel Cites Heart Attacks, Strokes, and Severe Skin Reactions Bextra, Pfizer’s anti-inflammatory drug for arthritis patients, will not be returned to the Canadian market according to a Health Canada announcement in…
-
Large Study to Investigate Heart Risks Of Celebrex, Ibuprofen, and Naproxen
Cleveland Clinic’s Dr. Nissen To Lead 20,000 Patient "Precision" Clinical Trial In mid-December 2005 the drug company Pfizer Inc. announced that Dr. Steven E. Nissen, medical director of the Cleveland Clinic’s cardiovascular coordinating center,…
-
Ortho Evra Lawsuits May Get MDL Status in Federal Court System
Birth Control Patch Allegedly Causes Serious Cardiovascular Problems Late in 2005, a motion was filed with the Judicial Panel on Multidistrict Litigation (JPML) by a plaintiff’s lawyer requesting the consolidation of all federal court…
-
Study On Cardiovascular Safety of Celebrex Reported at 2005 ACR Meeting
No Increased Risk Of Heart Attack Or Stroke For Patients Taking Celebrex According to a meta-analysis reported by Dr. Lee Simon, Associate Clinical Professor of Medicine at Harvard Medical School, the COX-2 specific…
-
Safety Warning Issued For Ortho Evra Birth Control Skin Patch
FDA: Possible Increased Risk of Blood Clots For Ortho Evra Users In November 2005 the FDA announced that it had approved an updated label, or package insert, for the Ortho Evra contraceptive patch. The…